ニュース
The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...
Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
President Donald Trump's tax cut and spending bill faces a critical stress test on Wednesday as Republicans in the U.S. House ...
Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.
4 日on MSN
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...
16 時間on MSN
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
Key Takeaways Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine.The shot, ...
Novavax (NVAX) shares climbed more than 17% premarket on Monday after the long-delayed approval of its COVID-19 vaccine from ...
The U.S. Food and Drug Administration approved Novavax's Covid-19 vaccine with age restrictions after a six-week delay.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する